UPC

Universe Pharmaceuticals Stock Price

Symbol: NasdaqCM:UPCMarket Cap: US$2.0mCategory: Pharmaceuticals & Biotech

UPC Share Price Performance

US$3.69
-2270.31 (-99.84%)
US$3.69
-2270.31 (-99.84%)
Price US$3.69

UPC Community Narratives

There are no narratives available yet.

Recent UPC News & Updates

No updates

Universe Pharmaceuticals INC Key Details

US$19.3m

Revenue

US$13.4m

Cost of Revenue

US$5.9m

Gross Profit

US$15.5m

Other Expenses

-US$9.6m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-17.08
Gross Margin
30.41%
Net Profit Margin
-49.87%
Debt/Equity Ratio
14.0%

Universe Pharmaceuticals INC Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About UPC

Founded
1998
Employees
225
CEO
Gang Lai
WebsiteView website
www.universe-pharmacy.com

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sells of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Chinese Market Performance

  • 7 Days: 2.0%
  • 3 Months: 10.7%
  • 1 Year: 34.3%
  • Year to Date: 13.7%
The market has climbed 2.0% in the last 7 days, lead by the Industrials sector with a gain of 3.0%. The market is up 34% over the last 12 months. As for the next few years, earnings are expected to grow by 24% per annum. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading